采用脑部和躯干[F]FDG PET/CT研究方案评估原发性和转移性脑肿瘤——单机构10年经验

Primary and Metastatic Brain Tumours Assessed with the Brain and Torso [F]FDG PET/CT Study Protocol-10 Years of Single-Institutional Experiences.

作者信息

Pietrzak Agata, Marszałek Andrzej, Piotrowski Tomasz, Medak Adrianna, Pietrasz Katarzyna, Wojtowicz Julia, Szweda Hubert, Matuszewski Krzysztof, Cholewiński Witold

机构信息

Electroradiology Department, Poznan University of Medical Sciences, 61-866 Poznan, Poland.

Nuclear Medicine Department, Greater Poland Cancer Centre, 61-866 Poznan, Poland.

出版信息

Pharmaceuticals (Basel). 2021 Jul 26;14(8):722. doi: 10.3390/ph14080722.

DOI:10.3390/ph14080722

PMID:34451818

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8401235/

Abstract

According to the international societies' recommendations, the 2-deoxy-2-[F]fluoro-D-glucose positron emission tomography/computed tomography ([F]FDG PET/CT) technique should not be used as the method of choice in brain tumour diagnosis. Therefore, the brain region can be omitted during standard [F]FDG PET/CT scanning. We performed comprehensive literature research and analysed results from 14,222 brain and torso [F]FDG PET/CT studies collected in 2010-2020. We found 131 clinically silent primary and metastatic brain tumours and 24 benign lesions. We concluded that the brain and torso [F]FDG PET/CT study provides valuable data that may support therapeutic management by detecting clinically silent primary and metastatic brain tumours.

摘要

根据国际学会的建议，2-脱氧-2-[F]氟-D-葡萄糖正电子发射断层扫描/计算机断层扫描（[F]FDG PET/CT）技术不应作为脑肿瘤诊断的首选方法。因此，在标准的[F]FDG PET/CT扫描过程中可以省略脑区。我们进行了全面的文献研究，并分析了2010年至2020年收集的14222例脑部和躯干[F]FDG PET/CT研究的结果。我们发现了131例临床无症状的原发性和转移性脑肿瘤以及24例良性病变。我们得出结论，脑部和躯干[F]FDG PET/CT研究提供了有价值的数据，这些数据可能通过检测临床无症状的原发性和转移性脑肿瘤来支持治疗管理。